Cargando…
Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutami...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193762/ https://www.ncbi.nlm.nih.gov/pubmed/11877487 http://dx.doi.org/10.1084/jem.20012028 |
_version_ | 1782147546366345216 |
---|---|
author | Vader, L. Willemijn de Ru, Arnoud van der Wal, Yvonne Kooy, Yvonne M.C. Benckhuijsen, Willemien Mearin, M. Luisa Drijfhout, Jan Wouter van Veelen, Peter Koning, Frits |
author_facet | Vader, L. Willemijn de Ru, Arnoud van der Wal, Yvonne Kooy, Yvonne M.C. Benckhuijsen, Willemien Mearin, M. Luisa Drijfhout, Jan Wouter van Veelen, Peter Koning, Frits |
author_sort | Vader, L. Willemijn |
collection | PubMed |
description | Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing between glutamine and proline, the second most abundant amino acid in gluten, plays an essential role in the specificity of deamidation. On the basis of this, algorithms were designed and used to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but not in the avenins from oats. The avenins contain significantly lower percentages of proline residues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino acid composition of gluten and related proteins in barley and rye favors the generation of toxic T cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac disease patients are intolerant to these cereal proteins but not to other common food proteins. |
format | Text |
id | pubmed-2193762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21937622008-04-14 Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease Vader, L. Willemijn de Ru, Arnoud van der Wal, Yvonne Kooy, Yvonne M.C. Benckhuijsen, Willemien Mearin, M. Luisa Drijfhout, Jan Wouter van Veelen, Peter Koning, Frits J Exp Med Brief Definitive Report Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing between glutamine and proline, the second most abundant amino acid in gluten, plays an essential role in the specificity of deamidation. On the basis of this, algorithms were designed and used to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but not in the avenins from oats. The avenins contain significantly lower percentages of proline residues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino acid composition of gluten and related proteins in barley and rye favors the generation of toxic T cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac disease patients are intolerant to these cereal proteins but not to other common food proteins. The Rockefeller University Press 2002-03-04 /pmc/articles/PMC2193762/ /pubmed/11877487 http://dx.doi.org/10.1084/jem.20012028 Text en Copyright © 2002, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Brief Definitive Report Vader, L. Willemijn de Ru, Arnoud van der Wal, Yvonne Kooy, Yvonne M.C. Benckhuijsen, Willemien Mearin, M. Luisa Drijfhout, Jan Wouter van Veelen, Peter Koning, Frits Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease |
title | Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease |
title_full | Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease |
title_fullStr | Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease |
title_full_unstemmed | Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease |
title_short | Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease |
title_sort | specificity of tissue transglutaminase explains cereal toxicity in celiac disease |
topic | Brief Definitive Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193762/ https://www.ncbi.nlm.nih.gov/pubmed/11877487 http://dx.doi.org/10.1084/jem.20012028 |
work_keys_str_mv | AT vaderlwillemijn specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT deruarnoud specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT vanderwalyvonne specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT kooyyvonnemc specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT benckhuijsenwillemien specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT mearinmluisa specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT drijfhoutjanwouter specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT vanveelenpeter specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease AT koningfrits specificityoftissuetransglutaminaseexplainscerealtoxicityinceliacdisease |